Erika Wats
January 8 2021

A recent paper examining existing evidence argues that SARS-CoV-2 infection might increase the risk of long-term neurological problems, including cognitive decline and dementia.

Nearly 1 year after the novel coronavirus, SARS-CoV-2, was identified, global cases have surpassed 88 million. Although a number of vaccines have been approved, the rollout will take time.
In the meantime, researchers continue studying COVID-19 in an attempt to slow the spread and reduce severe symptoms.
Other scientists are trying to piece together a picture of what life may look like in the long run for someone who has had COVID-19.

Read more: